Overview
Wenli Zhao practices practicing medicine in Shanghai, China.
Their clinical expertise encompasses Cerebral Hypoxia, Follicular Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Leukemia.
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Wenli Zhao
Is Wenli Zhao a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Wenli Zhao is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Wenli Zhao participate in research or clinical trials?
Yes. Wenli Zhao has published 22 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Wenli Zhao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Cerebral HypoxiaZhao isExperienced. Learn about Cerebral Hypoxia.
- Follicular LymphomaZhao isExperienced. Learn about Follicular Lymphoma.
- LeukemiaZhao isExperienced. Learn about Leukemia.
- Non-Hodgkin LymphomaZhao isExperienced. Learn about Non-Hodgkin Lymphoma.